RACHEL GUTIERREZ: Open Payments
NPI 1629480975 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 23 payments from 9 companies in 2025. Trend: 2023 $583 · 2024 $660 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $61 |
| Novo Nordisk Inc | 2 | $61 |
| Abbott Laboratories | 2 | $50 |
| ABIOMED | 1 | $22 |
| Becton, Dickinson and Company | 1 | $18 |
Products named: LifeVest, LEQVIO, FARXIGA, Wegovy, REPATHA, OPSUMIT, OPSYNVI, TRICLIP.
Industry payments across NC — which companies pay providers there.
